医学
指南
2型糖尿病
糖尿病
人口
低血糖
内科学
重症监护医学
二甲双胍
减肥
2型糖尿病
达帕格列嗪
不利影响
冲程(发动机)
血糖性
内分泌学
肥胖
病理
机械工程
环境卫生
工程类
作者
Amir Qaseem,Adam J. Obley,Tatyana Shamliyan,Lauri A. Hicks,Curtis S. Harrod,Carolyn Crandall,Ethan M. Balk,Thomas G. Cooney,J. Thomas Cross,Nick Fitterman,Jennifer S Lin,Michael Maroto,Matthew C. Miller,Paul Shekelle,Jeffrey A. Tice,Janice Tufte,Itziar Etxeandia‐Ikobaltzeta,Jennifer Yost,Amir Qaseem,Adam J. Obley
摘要
ACP recommends against adding a dipeptidyl peptidase-4 (DPP-4) inhibitor to metformin and lifestyle modifications in adults with type 2 diabetes and inadequate glycemic control to reduce morbidity and all-cause mortality (strong recommendation; high-certainty evidence).
科研通智能强力驱动
Strongly Powered by AbleSci AI